Asian stocks are set for a muted open with several regional markets still shut for holidays. Sentiment may remain generally ...

Novo Nordisk surges after U.S. regulators approve the first GLP-1 pill, while shares of rival pharma giant Eli Lilly decline.

Here are 10 of CFRA analysts' top growth stocks to buy that have reported at least 15% annual revenue growth in the past ...

Bank of America's Vivek Arya sees a 30% surge in chip sales and a $900 billion accelerator market just over the horizon.

The Danish drugmaker will start selling a pill version of its Wegovy weight-loss medicine in January, after [securing ...

Japan’s stocks are expected to extend gains in 2026, with Prime Minister Sanae Takaichi’s aggressive fiscal plans building on ...

This is the fourth in a series of articles in which I'm ranking the best "Magnificent Seven" stocks to buy for 2026, in ...

Major stock indexes ended higher Wednesday in a shortened session ahead of a Christmas closure, with the Dow Jones Industrial ...

REITs are out of favor, offering dividend investors a chance to buy industry leaders while they have attractive yields.

Some publicly traded quantum computing firms have seen their shares grow significantly in 2025. Whether it continues into ...

The semiconductor sector is poised for stronger growth in 2026, positioning some of the top names in this sector for solid gains.

Despite Warren Buffett’s impending departure, these five stocks are likely to stay in the Berkshire Hathaway portfolio for ...